Information  X 
Enter a valid email address

XL TechGroup, Inc. (XLT)

  Print   

Monday 12 June, 2006

XL TechGroup, Inc.

Arysta licensing agreement

XL TechGroup, Inc.
12 June 2006


Press Release                                                       12 June 2006



                               XL TechGroup, Inc.


                       ('XL TechGroup' or 'the Company')


                  XL TechGroup company, TyraTech, signs global

                  licensing agreement with Arysta LifeScience


XL TechGroup (AIM: XLT), the systematic architect and builder of an ongoing
stream of high value new companies, announces that its portfolio company,
TyraTech LLC ('TyraTech'), has signed a global licensing and co-development
agreement with the North American subsidiary of Japan based Arysta LifeScience
Corporation.


Headquartered in Tokyo, Japan, Arysta LifeScience Corporation is the world's
largest privately held crop protection and life science company with 2005
revenues of Y115.7 billion (US$1 billion).  Arysta LifeScience Corporation
specialises in the marketing and distribution of respected crop protection
brands and life science products in more than 60 countries worldwide.


Under this agreement, Arysta LifeScience has an exclusive license to manufacture
and market a number of specific horticultural insecticide products.  TyraTech
will receive payments from Arysta LifeScience covering development milestones,
followed by a revenue based royalty structure following product launch.  This
new relationship between Arysta LifeScience and TyraTech will capitalise on the
significant global opportunity for horticulture products based on highly
effective, natural active ingredients.  The horticultural insecticide market is
estimated to be US$3.7 billion worldwide.


TyraTech has a unique biotechnology platform that has been applied to the
creation of an entirely new class of natural insecticides that are highly
effective, as demonstrated by independent trials, and are designed to retard
insect resistance.  The core technology, which uses the successful reproduction
of chemo receptors in a stable cell line to identify highly effective essential
oil compounds, has a wide variety of applications.  The ingredients are based on
natural plant oils, which are environmentally-friendly and designed to be
harmless for both humans and animals.


'The natural and highly effective active ingredient solutions provided by
TyraTech will allow us to further meet our customers' needs,' said Bill Lewis,
president and CEO of Arysta LifeScience North America Corporation.  'Customers
want new active ingredient compounds that are less likely to develop insect
resistance, to improve the efficacy and environmental profile of their
integrated pest management efforts.  We are enthusiastic about the potential of
TyraTech's platform technology to allow us to meet the substantial and growing
market need for natural, highly effective active ingredients across a broad
range of horticultural applications.  Together, we will become leaders in
horticultural natural insecticides.'


John Scott, CEO of XL TechGroup, said: 'This agreement with a global leader like
Arysta LifeScience represents a further significant endorsement for TyraTech and
its market-changing, disruptive technologies.  In the world of horticulture,
many pests have developed resistance to classic insecticides.  As a result, the
growing worldwide horticulture insecticide market is looking for safe, natural
solutions that work, and TyraTech is perfectly positioned to bring its unique
technology and experience to bear.'


'TyraTech's technology is specifically designed to retard the development of
resistance in insects through a simultaneous focus on a combination of
chemo-receptors, which not only dramatically reduces the potential for
resistance but also enables the rapid development of new highly focused
insecticides when needed.  This agreement represents another step in expanding
the range of potential applications for TyraTech's technologies, and we look
forward to making further announcements over the coming months.'



                                    - Ends -



For further information:
XL TechGroup Inc.
John Scott / Harold Gubnitsky                               Tel: +1 321 409 7403
[email protected]                                          www.xltechgroup.com
Arysta LifeScience
Donna Uchida                                                Tel: +1 415 309 9636
[email protected]                     www.arystalifescience.com



XL TechGroup media enquiries:
Abchurch Communications
Heather Salmond / Gareth Mead                          Tel: +44 (0) 20 7398 7700
[email protected]                        www.abchurch-group.com





NOTES TO EDITORS



About XL TechGroup

XL TechGroup identifies unmet market needs in the Biotech, Ecotech and Medtech
sectors and then systematically creates and develops successful disruptive
technology businesses to exploit these needs.  The Company has developed a
unique proven method to rapidly bring companies from inception to liquidity,
matching unexploited IP from a group of corporate and technology partners to the
identified unmet market need.  XL TechGroup employs its own predictive algorithm
to ensure the market will rapidly adopt the identified solution and then moves
to scale the company specifically created to exploit the opportunity.


Before forming XL TechGroup, the management team created substantial value for
shareholders over a twelve year period, successfully exiting six technology
businesses at an average market valuation of approximately US$500 million.


The listing of the first company created under the XL TechGroup banner, AgCert
International, continues to validate the systematic approach to value creation.


•    AgCert International was created by XL TechGroup in May 2002 and is a
     global leader in the production and sale of agriculturally derived 
     greenhouse gas emission reductions, with business in Europe, Asia, North 
     America and South America.  AgCert was listed on the London Stock Exchange
     in June 2005 and XL TechGroup maintains a 24.7% interest in AgCert.  
     www.agcert.com


The second and third companies in the new generation of XL TechGroup businesses
are:


•    TyraTech LLC, which was created by XL TechGroup in July 2004, is
     developing a new class of insecticides utilizing all natural active 
     ingredients. TyraTech is able to quickly evaluate natural ingredient 
     combinations by utilizing a patent-pending high throughput chemoreceptor 
     screening process that accurately predicts effectiveness levels.  
     TyraTech's development is progressing rapidly in both insecticidal and 
     related human healthcare applications. TyraTech, which is 66.7% owned by 
     XL TechGroup, is continuing discussions with companies in North America, 
     Asia and Europe as well as numerous national public health programs about 
     the licensing and distribution rights for its patent-pending formulations 
     in relation to natural insecticide and personal care products.  
     www.tyratech.com


•    DxTech LLC was created by XL TechGroup in July 2005, and is developing a 
     unique micro-fluidic platform that replaces essentially all biological 
     tests currently performed at reference laboratories with a fully-automated,
     point-of-care device.  This technology has applications in significantly
     lowering costs and increasing efficiency for major pharmaceutical companies
     in their clinical trials, the provision of diagnostics in developing 
     countries and delivering a new revenue stream for doctors in the USA.  
     DxTech is currently 100% owned by XL TechGroup.


XL TechGroup has a number of other opportunities already at an advanced stage in
its business creation pipeline, and expects to create one-to-two new companies
annually that can each achieve a liquidity event worth at least US$400 million
within four years from inception.


For further information, see www.xltechgroup.com



About Arysta

Headquartered in Tokyo, Japan, Arysta LifeScience is the world's largest
privately held crop protection and life science company with 2005 revenues of Y
115.7 billion (US$1 billion).  An entrepreneurial provider of crop protection
and life science products in more than 125 countries worldwide, Arysta
LifeScience specializes in the marketing and distribution of respected crop
protection brands and life science products in harmony with the needs of global
producers.


For further information, see www.arystalifescience.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange                            

a d v e r t i s e m e n t